Viruses are constantly evolving, and this evolution can sometimes lead to changes in their classification. Two viruses that are likely to be reclassified in the near future are herpes and Zika.

Herpes

Herpes is a common virus that can cause a variety of symptoms, including cold sores, genital herpes, and chickenpox. It is currently classified as a member of the herpesvirus family, but researchers are now proposing that it be reclassified as a member of the poxvirus family.

This reclassification is based on several factors, including the fact that herpes viruses and poxviruses share a number of similarities in their genome and structure. Additionally, both herpes viruses and poxviruses can cause infections of the skin and mucous membranes.

The reclassification of herpes as a poxvirus could have a number of implications for biotech research. For example, it could lead to the development of new drugs and vaccines for herpes that are based on the research that has been done on poxviruses.

Zika

Zika is a mosquito-borne virus that can cause a variety of symptoms, including fever, rash, muscle pain, and joint pain. In some cases, Zika can also cause serious birth defects in babies born to women who are infected with the virus during pregnancy.

Zika is currently classified as a member of the flavivirus family, but researchers are now proposing that it be reclassified as a member of the togavirus family.

This reclassification is based on several factors, including the fact that Zika viruses and togaviruses share a number of similarities in their genome and structure. Additionally, both Zika viruses and togaviruses can be transmitted by mosquitoes.

The reclassification of Zika as a togavirus could have a number of implications for biotech research. For example, it could lead to the development of new drugs and vaccines for Zika that are based on the research that has been done on togaviruses.

Conclusion

The reclassification of viruses like herpes and Zika is a complex process that involves a number of factors. However, these reclassifications could have a number of important implications for biotech research, leading to the development of new drugs and vaccines for these viruses.